HABERLER VE DUYURULARLaboratories2017-07-03glry ← ÖNCEKİAssigned as a MC Member in a COST action, Dr. Mehmet Hikmet Üçışık will study on development of novel drug delivery systems for the treatment of leishmaniasisSONRAKİ →ExperimentsTüm haberler
